279 related articles for article (PubMed ID: 2271083)
1. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
3. Renal allograft immunosuppression. I. Early inflammatory and rejection episodes in triple drug treatment compared to double drug combinations or cyclosporin monotherapy.
Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
Transpl Int; 1990 Jul; 3(2):92-7. PubMed ID: 2206227
[TBL] [Abstract][Full Text] [Related]
4. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
Isoniemi H; Tikkanen MJ; Ahonen J; Häyry P
Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
[TBL] [Abstract][Full Text] [Related]
5. Renal allograft immunosuppression. VI. Triple drug therapy versus immunosuppressive double drug combinations: histopathological findings in renal allografts.
Isoniemi H; Krogerus L; von Willebrand E; Taskinen E; Grönhagen-Riska C; Ahonen J; Häyry P
Transpl Int; 1991 Sep; 4(3):151-6. PubMed ID: 1958279
[TBL] [Abstract][Full Text] [Related]
6. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
7. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
8. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
[TBL] [Abstract][Full Text] [Related]
9. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
10. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
13. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
[TBL] [Abstract][Full Text] [Related]
14. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S
Cas Lek Cesk; 2000 Mar; 139(4):115-9. PubMed ID: 10838741
[TBL] [Abstract][Full Text] [Related]
15. Low-dose ciclosporin, prednisone, and azathioprine after initial immunosuppression with ciclosporin and prednisone in a pediatric renal transplant population.
Turner MC
Child Nephrol Urol; 1990; 10(3):125-30. PubMed ID: 2285916
[TBL] [Abstract][Full Text] [Related]
16. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity.
Klaus G; Jeck N; Konrad M; Förster B; Soergel M
Clin Nephrol; 2001 Dec; 56(6):S37-42. PubMed ID: 11770812
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine as primary therapy for A-matched living related donor kidney graft recipients.
MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1667-9. PubMed ID: 2652546
[TBL] [Abstract][Full Text] [Related]
18. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
19. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
[No Abstract] [Full Text] [Related]
20. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
